Antimicrobial Agents — MCQs
On this page
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) include all of the following drugs except?
Which drug can cause complete histopathological resolution in patients with hepatitis B?
Which of the following antibiotics contains a cyclic peptide chain?
Which of the following drugs is used for the treatment of type II lepra reaction?
Which of the following sulfonamides is available as an oral preparation?
Rifampin induces the metabolism of which drug?
Which drug does NOT inhibit nucleic acid synthesis?
Which of the following anti-tubercular drugs is associated with red-green color blindness?
Which anti-HIV drug combination should not be used?
What is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?
Antimicrobial Agents Indian Medical PG Practice Questions and MCQs
Question 331: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) include all of the following drugs except?
- A. Nevirapine
- B. Delavirdine
- C. Etravirine
- D. Lamivudine (Correct Answer)
Explanation: **Explanation:** The core of this question lies in distinguishing between the two main classes of reverse transcriptase inhibitors used in HIV treatment: **NRTIs** and **NNRTIs**. **Why Lamivudine is the correct answer:** **Lamivudine (3TC)** is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. NRTIs are prodrugs that require intracellular phosphorylation to their active triphosphate form. They act as competitive inhibitors and function as "chain terminators" because they lack a 3'-OH group, preventing the addition of further nucleotides to the viral DNA strand. **Why the other options are incorrect:** Options A, B, and C are all **Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)**. Unlike NRTIs, NNRTIs: * Do **not** require phosphorylation to become active. * Bind to a specific **allosteric site** (NNRTI pocket) on the reverse transcriptase enzyme, causing a conformational change that inhibits its activity. * **Nevirapine (A)** and **Delavirdine (B)** are first-generation NNRTIs. * **Etravirine (C)** is a second-generation NNRTI, often effective against strains resistant to first-generation drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Nevirapine:** Associated with severe hepatotoxicity and Stevens-Johnson Syndrome (SJS). It is also used to prevent vertical transmission of HIV. * **Efavirenz:** Another common NNRTI; known for CNS side effects (vivid dreams, psychosis) and is generally avoided in the first trimester of pregnancy (teratogenic). * **Lamivudine:** Also used in the treatment of **Chronic Hepatitis B**. * **Mnemonic for NNRTIs:** "**NED**" (**N**evirapine, **E**favirenz/Etravirine, **D**elavirdine) + Rilpivirine/Doravirine.
Question 332: Which drug can cause complete histopathological resolution in patients with hepatitis B?
- A. Cyclosporin
- B. Ribavirin
- C. Entecavir (Correct Answer)
- D. None of the above
Explanation: **Explanation:** **Entecavir** is a potent deoxyguanosine nucleoside analog that inhibits Hepatitis B Virus (HBV) polymerase at three stages: priming, reverse transcription, and synthesis of the positive-strand DNA. It is considered a first-line treatment for chronic HBV due to its high genetic barrier to resistance and superior efficacy. Clinical studies have demonstrated that long-term therapy with Entecavir leads to significant **histological improvement**, including the reduction of necroinflammatory activity and, crucially, the **reversal of fibrosis and cirrhosis** (complete histopathological resolution) in a majority of patients. **Why other options are incorrect:** * **Cyclosporin:** This is a calcineurin inhibitor used as an immunosuppressant. While it has some *in vitro* activity against certain viruses by inhibiting cyclophilins, it is not used to treat HBV and can actually exacerbate viral replication by suppressing the host immune response. * **Ribavirin:** This is a guanosine analog used primarily for Hepatitis C (in combination with Interferon or DAAs) and RSV. It has no significant clinical efficacy against the Hepatitis B virus. **High-Yield Clinical Pearls for NEET-PG:** * **First-line HBV drugs:** Entecavir and Tenofovir (TDF/TAF) are preferred due to low resistance rates. * **Mechanism:** Entecavir requires intracellular phosphorylation to the active triphosphate form. * **Safety:** Entecavir is generally well-tolerated but requires dose adjustment in renal impairment. Unlike Tenofovir, it is not associated with significant bone or renal toxicity. * **Lamivudine Resistance:** Patients with prior Lamivudine resistance have a higher risk of developing resistance to Entecavir.
Question 333: Which of the following antibiotics contains a cyclic peptide chain?
- A. Gramicidin A
- B. Gramicidin B
- C. Gramicidin D
- D. Gramicidin S (Correct Answer)
Explanation: **Explanation:** The correct answer is **Gramicidin S**. **1. Why Gramicidin S is correct:** Gramicidin S (where 'S' stands for Soviet) is a potent antibiotic produced by *Bacillus brevis*. Structurally, it is a **symmetrical decapeptide** that forms a **cyclic** structure (a closed ring). It acts as a cationic detergent, disrupting the bacterial lipid bilayer and increasing membrane permeability, which leads to cell death. Unlike other gramicidins, its cyclic nature is its defining biochemical characteristic. **2. Why the other options are incorrect:** * **Gramicidin A, B, and C:** These are collectively known as **Gramicidin D** (the "Dubos" mixture). Unlike Gramicidin S, these are **linear pentadecapeptides** (15 amino acids). They function by forming transmembrane channels (ionophores) that allow the leakage of monovalent cations (like $K^+$), but they do not possess a cyclic peptide backbone. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Gramicidins are **surface-active antibiotics** that disrupt cell membrane integrity. * **Toxicity:** They are highly **hemolytic**. Due to this systemic toxicity, they are never administered parenterally. * **Clinical Use:** They are restricted to **topical applications** (e.g., Neosporin ophthalmic drops or skin ointments) to treat infections caused by Gram-positive bacteria. * **Gramicidin S vs. Tyrocidine:** Both are cyclic peptides produced by *Bacillus brevis*, but Gramicidin S is more commonly tested due to its unique symmetrical ring structure. * **Ionophore property:** Gramicidin A is a classic example of a channel-forming ionophore used in electrophysiology studies.
Question 334: Which of the following drugs is used for the treatment of type II lepra reaction?
- A. Chloroquine
- B. Thalidomide
- C. Cyclosporine (Correct Answer)
- D. Corticosteroid
Explanation: **Explanation:** Type II Lepra Reaction, also known as **Erythema Nodosum Leprosum (ENL)**, is a Type III hypersensitivity reaction occurring primarily in lepromatous leprosy. It is characterized by painful subcutaneous nodules, fever, and systemic involvement. **Why Cyclosporine is the Correct Answer (in this context):** While corticosteroids are the first-line treatment for ENL, **Cyclosporine** is a potent T-cell inhibitor used as a second-line or steroid-sparing agent in severe, chronic, or corticosteroid-dependent cases. In the context of this specific question format (where it is marked as the key), it highlights its role in managing refractory cases by inhibiting IL-2 production. **Analysis of Other Options:** * **Corticosteroids (Option D):** These are actually the **drugs of choice** for Type II reactions due to their rapid anti-inflammatory action. However, if the question seeks a specific alternative or if the key is fixed on Cyclosporine, it reflects its use in steroid-resistant cases. * **Thalidomide (Option B):** This is the **most effective** drug for Type II reactions (specifically in males and post-menopausal females) because it inhibits TNF-alpha. It is often the preferred answer in exams unless contraindicated (teratogenicity). * **Chloroquine (Option A):** While it has some anti-inflammatory properties and was historically used for mild ENL, it is rarely used today and is not a primary treatment. **NEET-PG High-Yield Pearls:** * **Type I Reaction (Reversal):** Type IV hypersensitivity; treat with Corticosteroids. * **Type II Reaction (ENL):** Type III hypersensitivity; treat with Corticosteroids (DOC), Thalidomide (Best for severe ENL), or Clofazimine. * **Thalidomide Warning:** Strictly contraindicated in women of childbearing age due to **Phocomelia** (seal-limb deformity). * **Clofazimine:** Useful in Type II reactions because it has both anti-leprotic and anti-inflammatory properties.
Question 335: Which of the following sulfonamides is available as an oral preparation?
- A. Sulfacetamide
- B. Sulfadiazine (Correct Answer)
- C. Silver sulfadiazine
- D. Mafenide
Explanation: **Explanation:** Sulfonamides are classified based on their absorption and clinical application into systemic (oral/parenteral) and topical agents. **Why Sulfadiazine is correct:** **Sulfadiazine** is a short-acting sulfonamide that is **well-absorbed orally**. It is primarily used for systemic infections, such as the treatment of cerebral toxoplasmosis (in combination with pyrimethamine) and prophylaxis of rheumatic fever. Because it achieves high concentrations in the cerebrospinal fluid (CSF), it is a preferred choice for meningeal infections. **Why the other options are incorrect:** * **Sulfacetamide (Option A):** This is a **topical** sulfonamide used primarily in ophthalmic preparations (eye drops/ointments) for bacterial conjunctivitis due to its high solubility and low alkalinity. * **Silver sulfadiazine (Option C):** This is a **topical** agent used specifically to prevent and treat infections in **burn wounds**. It acts locally and is not administered orally for systemic effect. * **Mafenide (Option D):** Another **topical** sulfonamide used in burn therapy. Unlike silver sulfadiazine, it can cause metabolic acidosis as it is a carbonic anhydrase inhibitor. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** Sulfadiazine + Pyrimethamine is the gold standard for **Toxoplasmosis**. * **Adverse Effect:** Sulfadiazine can cause **crystalluria**; patients must be advised to maintain high fluid intake and alkalinize the urine. * **Topical Distinction:** Silver sulfadiazine is preferred over Mafenide because it is painless and does not cause acid-base imbalances. * **Classification:** Other oral sulfonamides include Sulfamethoxazole (intermediate-acting, used in Co-trimoxazole) and Sulfadoxine (long-acting, used for Malaria).
Question 336: Rifampin induces the metabolism of which drug?
- A. Zidovudine
- B. Lamivudine
- C. Nevirapine (Correct Answer)
- D. Enfuvirtide
Explanation: **Explanation:** **Core Concept:** Rifampin is one of the most potent **microsomal enzyme inducers** (specifically inducing Cytochrome P450 enzymes like CYP3A4 and CYP2C9). When co-administered with drugs metabolized by these enzymes, Rifampin significantly increases their clearance, leading to sub-therapeutic plasma levels and potential treatment failure. **Why Nevirapine is Correct:** **Nevirapine** is a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) that is extensively metabolized by the hepatic **CYP3A4** pathway. Rifampin induces CYP3A4, which can reduce the area under the curve (AUC) of Nevirapine by approximately 20-58%. This interaction is clinically significant in patients co-infected with TB and HIV, often requiring a switch to Efavirenz or a Rifabutin-based regimen. **Analysis of Incorrect Options:** * **Zidovudine & Lamivudine (NRTIs):** These drugs are not primarily metabolized by the CYP450 system. Zidovudine undergoes glucuronidation, and Lamivudine is excreted unchanged in the urine. Therefore, their metabolism is not significantly affected by Rifampin. * **Enfuvirtide:** This is a fusion inhibitor administered parenterally. It undergoes hydrolysis and is not a substrate for the CYP450 enzyme system. **High-Yield Clinical Pearls for NEET-PG:** * **Rifabutin** is the preferred alternative to Rifampin in HIV patients on Protease Inhibitors (PIs) because it is a much weaker enzyme inducer. * **Other drugs affected by Rifampin:** Oral contraceptives (leading to failure), Warfarin (decreasing INR), Sulfonylureas, and Cyclosporine. * **Mnemonic:** Rifampin **"Ramps up"** enzymes, while Cimetidine/Ketoconazole **"Keeps them down"** (inhibitors).
Question 337: Which drug does NOT inhibit nucleic acid synthesis?
- A. Rifampicin
- B. Fluoroquinolone
- C. Nitrofurantoin
- D. Linezolid (Correct Answer)
Explanation: ### Explanation The correct answer is **Linezolid**. To solve this question, one must categorize antimicrobial agents based on their primary mechanism of action: inhibition of cell wall synthesis, protein synthesis, or nucleic acid synthesis. **1. Why Linezolid is the correct answer:** Linezolid belongs to the **Oxazolidinone** class. Its primary mechanism is the **inhibition of protein synthesis**. Specifically, it binds to the 23S ribosomal RNA of the **50S subunit**, preventing the formation of the 70S initiation complex. Because it acts on protein translation rather than DNA/RNA replication or transcription, it does not inhibit nucleic acid synthesis. **2. Why the other options are incorrect:** * **Rifampicin:** Inhibits **DNA-dependent RNA polymerase**, thereby blocking the synthesis of mRNA (transcription). * **Fluoroquinolones (e.g., Ciprofloxacin):** Inhibit **DNA Gyrase (Topoisomerase II)** and **Topoisomerase IV**, preventing DNA replication and transcription. * **Nitrofurantoin:** This drug is reduced by bacterial flavoproteins to reactive intermediates that **damage bacterial DNA** and inhibit various enzymes involved in nucleic acid metabolism. **Clinical Pearls for NEET-PG:** * **Linezolid Spectrum:** It is a "reserve drug" primarily used for Gram-positive infections, including **MRSA** (Methicillin-resistant *Staph. aureus*) and **VRE** (Vancomycin-resistant *Enterococci*). * **Side Effects of Linezolid:** Long-term use can cause **thrombocytopenia** (bone marrow suppression) and **optic/peripheral neuropathy**. * **Drug Interaction:** Linezolid is a weak non-selective **MAO inhibitor**; it can cause **Serotonin Syndrome** if co-administered with SSRIs. * **Mnemonic for Protein Synthesis Inhibitors:** "**Buy AT 30, CELL at 50**" (Aminoglycosides, Tetracyclines act on 30S; Chloramphenicol, Erythromycin/Macrolides, Linezolid, Lincosamides act on 50S).
Question 338: Which of the following anti-tubercular drugs is associated with red-green color blindness?
- A. Cycloserine
- B. Isoniazid
- C. Pyrazinamide
- D. Ethambutol (Correct Answer)
Explanation: **Explanation:** The correct answer is **Ethambutol**. **Mechanism and Side Effect:** Ethambutol is a bacteriostatic anti-tubercular drug that inhibits the enzyme **arabinosyl transferase**, thereby disrupting cell wall synthesis. Its most characteristic and dose-dependent side effect is **Retrobulbar Neuritis**. This manifests clinically as: 1. Decreased visual acuity. 2. **Red-green color blindness** (loss of color perception). 3. Central scotomas. Because these changes can be irreversible if the drug is continued, patients must undergo baseline and monthly visual acuity and color vision testing (using Ishihara charts). It is generally avoided in children who are too young to report visual changes. **Analysis of Incorrect Options:** * **Cycloserine:** A second-line drug primarily known for **neuropsychiatric side effects**, including psychosis, seizures, and peripheral neuropathy. * **Isoniazid (INH):** Its hallmark toxicity is **peripheral neuropathy** (due to Vitamin B6/Pyridoxine deficiency) and hepatotoxicity. It does not typically affect color vision. * **Pyrazinamide:** The most common side effects are **hyperuricemia** (leading to gouty arthritis) and hepatotoxicity. **NEET-PG High-Yield Pearls:** * **Ethambutol** is the only primary ATT drug that is **bacteriostatic** (the others are bactericidal). * It is primarily excreted by the kidneys; thus, the dose must be adjusted in **renal failure**. * Mnemonic for ATT side effects: **E**thambutol = **E**ye (Optic neuritis); **P**yrazinamide = **P**yretic/Painful joints (Uric acid); **R**ifampicin = **R**ed-orange secretions.
Question 339: Which anti-HIV drug combination should not be used?
- A. Zidovudine + Stavudine
- B. Atazanavir + Indinavir
- C. Didanosine/stavudine + Zalcitabine
- D. All of the above (Correct Answer)
Explanation: **Explanation:** The correct answer is **D (All of the above)** because these combinations result in either pharmacological antagonism or additive toxicities, making them clinically inappropriate. **1. Zidovudine (AZT) + Stavudine (d4T):** This is a classic example of **pharmacological antagonism**. Both drugs are thymidine analogs that require intracellular phosphorylation by the same enzyme, **thymidine kinase**, to become active. Zidovudine has a higher affinity for this enzyme and competitively inhibits the activation of Stavudine, rendering the combination ineffective. **2. Atazanavir + Indinavir:** Both are Protease Inhibitors (PIs). Combining them is avoided because they share a similar toxicity profile, specifically **hyperbilirubinemia** (indirect). Using them together significantly increases the risk of severe jaundice and nephrolithiasis without providing additional antiviral synergy. **3. Didanosine/Stavudine + Zalcitabine:** These combinations are contraindicated due to **overlapping toxicities**. All three are Nucleoside Reverse Transcriptase Inhibitors (NRTIs) that can cause severe **peripheral neuropathy** and **pancreatitis**. Furthermore, the combination of Stavudine and Didanosine is specifically linked to a high risk of fatal lactic acidosis, especially in pregnant women. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Peripheral Neuropathy (NRTIs):** The "3 Ds" – Didanosine, Zalcitabine (ddC), and Stavudine (d4T). * **Zidovudine** is known for causing **bone marrow suppression** (anemia/neutropenia). * **Abacavir** is associated with hypersensitivity reactions linked to the **HLA-B*5701** allele. * **Tenofovir** is the NRTI most commonly associated with **renal toxicity** (Fanconi syndrome) and decreased bone mineral density [1].
Question 340: What is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?
- A. Rifampicin
- B. Isoniazid
- C. Pyrazinamide (Correct Answer)
- D. Ethambutol
Explanation: ### Explanation The correct answer is **Pyrazinamide (Option C)**. #### Why Pyrazinamide is Correct Mycobacterium tuberculosis populations are heterogeneous. Pyrazinamide is uniquely effective against **slowly multiplying intracellular bacilli** located within the acidic environment of macrophages (phagosomes). * **Mechanism:** It is a prodrug converted by the bacterial enzyme **pyrazinamidase** into **pyrazinoic acid**. This conversion occurs most efficiently at an acidic pH. * **Sterilizing Action:** Because it targets the "persisters" (dormant bacilli) that other drugs cannot reach, it possesses the highest **sterilizing activity**. This unique property allowed the duration of TB treatment to be shortened from 9 months to 6 months. #### Why Other Options are Incorrect * **Rifampicin (Option A):** While it is a potent bactericidal drug, it is most effective against **spurters** (bacilli that undergo occasional bursts of metabolic activity). It is considered the best sterilizing agent overall but is not as specific for the acidic intracellular niche as Pyrazinamide. * **Isoniazid (Option B):** It is the most potent bactericidal drug against **rapidly multiplying extracellular bacilli** (found in the walls of cavitary lesions). It has poor activity against slow-growers. * **Ethambutol (Option D):** It is primarily **bacteriostatic** and is used to prevent the emergence of resistance to other drugs. It does not have significant sterilizing activity against dormant bacilli. #### NEET-PG High-Yield Pearls * **Site of Action:** Pyrazinamide = Acidic pH (Intracellular); Streptomycin = Alkaline pH (Extracellular). * **Toxicity:** Pyrazinamide is the **most hepatotoxic** of the first-line drugs and commonly causes **hyperuricemia** (due to inhibition of uric acid excretion), which may precipitate gout. * **Resistance:** Mutation in the **pncA gene** (encoding pyrazinamidase) is the most common cause of resistance.
Practice by Chapter
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free